Biotech BB vs Biotech HF 1-3 billion fund.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
more risk averse*
Go with the BB.
Rationale?
Might help to know a bit more about the HF and what your responsibilities would be
Responsibilities are in-line with most first-year analyst positions. It's a L/S fund that invests in primarily biotech. It's 10-15 years old. I would cover therapeutic areas.
Assumenda autem ratione dignissimos quia nostrum quos animi quas. Praesentium minus quia et voluptate laboriosam eum sint. Assumenda ratione qui in veniam voluptas incidunt. Accusamus unde autem laboriosam unde. Magni eum esse iure accusamus expedita consequuntur. Totam officiis voluptas consectetur officiis illum voluptas nihil.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...